Jecko Thachil/LinkedIn
Mar 14, 2026, 15:40
Jecko Thachil: Anticoagulation in Patients With Metabolic-Associated Fatty Liver Disease
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about about a recent article he and his colleagues co-authored, adding:
“Patients with liver disease were historically considered to be at increased risk of bleeding. But, now we know that such patients may actually be at increased risk of thrombosis, especially in setting of metabolic associated fatty liver disease or staetohepatitis.
How do we anticoagulate such patients?”
Title: The prothrombotic tendency of metabolic-associated fatty liver disease
Authors: Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil
Read the Full Article on Journal of Thrombosis and Haemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Apr 30, 2026, 18:19Deva Nanda TK: A Practical Overview of Dural Sinuses and The Venous Drainage of the Brain
-
Apr 30, 2026, 18:08Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
-
Apr 30, 2026, 18:06Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
-
Apr 30, 2026, 18:03Carmen Ruiz: First Arterial Mechanical Thrombectomy in New Zealand Using the ARTIX System
-
Apr 30, 2026, 17:52Simon Senanu: von Willebrand Disease May Be Missed Despite Normal Tests
-
Apr 30, 2026, 17:20José Antonio García Erce: Why Healthy Older Adults Should Keep Donating Blood?
-
Apr 30, 2026, 17:13Paul Logan: Decoding the Words ‘He’s on blood thinners’
-
Apr 30, 2026, 17:01Jason Andrade: A Decade-Long Quest Proves Early Ablation Halves Persistent AF Burden
-
Apr 30, 2026, 16:56Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC